Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 4394

Check out the on-demand sessions from the Low-Code/No-Code Summit to learn how to successfully innovate and achieve efficiency by upskilling and scaling citizen developers. Watch now.

A supercomputer, providing massive amounts of computing power to tackle complex challenges, is typically out of reach for the average enterprise data scientist. However, what if you could use cloud resources instead? That’s the rationale that Microsoft Azure and Nvidia are taking with this week’s announcement designed to coincide with the SC22 supercomputing conference.

Nvidia and Microsoft announced that they are building a “massive cloud AI computer.” The supercomputer in question, however, is not an individually-named system, like the Frontier system at the Oak Ridge National Laboratory or the Perlmutter system, which is the world’s fastest Artificial Intelligence (AI) supercomputer. Rather, the new AI supercomputer is a set of capabilities and services within Azure, powered by Nvidia technologies, for high performance computing (HPC) uses.

Read more | >

The global COVID-19 epidemic has spread rapidly around the world and caused the death of more than 5 million people. It is urgent to develop effective strategies to treat COVID-19 patients. Here, we revealed that SARS-CoV-2 infection resulted in the dysregulation of genes associated with NAD+ metabolism, immune response, and cell death in mice, similar to that in COVID-19 patients. We therefore investigated the effect of treatment with NAD+ and its intermediate (NMN) and found that the pneumonia phenotypes, including excessive inflammatory cell infiltration, hemolysis, and embolization in SARS-CoV-2-infected lungs were significantly rescued. Cell death was suppressed substantially by NAD+ and NMN supplementation. More strikingly, NMN supplementation can protect 30% of aged mice infected with the lethal mouse-adapted SARS-CoV-2 from death.

Read more | >

A tool for estimating the local entropy production rate of a system enables the visualization and quantification of the out-of-equilibrium regions of an active-matter system.

A movie of a molecule jostling around in a fluid at equilibrium looks the same when played forward and backward. Such a movie has an “entropy production rate”—the parameter used to quantify this symmetry—of zero; most other movies have a nonzero value, meaning the visualized systems are out of equilibrium. Researchers know how to compute the entropy production rate of simple model systems. But measuring this parameter in experiments is an open problem. Now Sungham Ro of the Technion-Israel Institute of Technology, Buming Guo of New York University, and colleagues have devised a method for making local measurements of the entropy production rate [1]. They demonstrate the technique using simulations and bacteria observations (Fig. 1).

Read more | >

Researchers at Penn Engineering have created a chip that outstrips the security and robustness of existing quantum communications hardware. Their technology communicates in “qudits,” doubling the quantum information space of any previous on-chip laser.

Liang Feng, Professor in the Departments of Materials Science and Engineering (MSE) and Electrical Systems and Engineering (ESE), along with MSE postdoctoral fellow Zhifeng Zhang and ESE Ph.D. student Haoqi Zhao, debuted the technology in a recent study published in Nature. The group worked in collaboration with scientists from the Polytechnic University of Milan, the Institute for Cross-Disciplinary Physics and Complex Systems, Duke University and the City University of New York (CUNY).

Read more | >

A new technology developed at Tel Aviv University makes it possible to destroy cancerous tumors in a targeted manner, via a combination of ultrasound and the injection of nanobubbles into the bloodstream. According to the research team, unlike invasive treatment methods or the injection of microbubbles into the tumor itself, this latest technology enables the destruction of the tumor in a non-invasive manner.

The study was conducted under the leadership of doctoral student Mike Bismuth from the lab of Dr. Tali Ilovitsh at Tel Aviv University’s Department of Biomedical Engineering, in collaboration with Dr. Dov Hershkovitz of the Department of Pathology. Prof. Agata Exner from Case Western Reserve University in Cleveland also participated in the study. The study was published in the journal Nanoscale.

Dr. Tali Ilovitsh says that their “new technology makes it possible, in a relatively simple way, to inject nanobubbles into the bloodstream, which then congregate in the area of the cancerous . After that, using a low-frequency ultrasound, we explode the nanobubbles, and thereby the tumor.”

Read more | >